Analystreport

Ovid Therapeutics Inc. (NASDAQ: OVID) was upgraded by analysts at William Blair to a "strong-buy" rating.

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com